IN THE NEWS
Press Release: Bioquell invests for future growth
Automated filling and capping systems Ten steps to preventing infection in hospitals... Award by the NHS Purchasing and Supply Agency to BIOQUELL DoH & PASA Publish report on Success of BIOQUELL System in Showcase Hospital Programme BIOQUELL assist with clean up BIOQUELL Launch new Clarus L2 HPV Generator Briefing on the outbreak of Swine Influenza Virus BIOQUELL takes top prize at the Department of Health HCAI Technology Innovation Summit BBC News Films 'New Weapons Against Hospital Bugs' at Lewisham Hospital Department of Health Press Release Robot set to tackle killer hospital bugs BIOQUELL moves to newly renovated production facility Infection Control & Hospital Epidemiology Article - Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile... BIOQUELL technology showcased in seven NHS hospitals Best foot forward for cleaner hospitals East Sussex Hospitals NHS Trust Commence Deployment of RBDS Proactive Team Gloucestershire Hospitals NHS Foundation Trust are the first UK hospital to deploy a BIOQUELL Proactive team. "Hydrogen Peroxide Vapor can control Nosocomial MRSA Outbreak" - Clinical Infectious Diseases Article Rapid Review Panel upgrades BIOQUELL technology to Level One Status Department of Health Post BIOQUELL Case Studies as "Best Practice" on website Award of Joint Material Decontamination System (US military) sub-contract Deep Cleaning Service from BIOQUELL Category III decontamination service launched |
Bioquell Healthcare Options: Tailored to your requirements
Bioquell's unique hydrogen peroxide vapour (HPV) decontamination technology is ideally suited for use in healthcare facilities due to its rapid, flexible and 'residue-free' nature. HPV has extensive, proven biological efficacy against a wide range of environmentally associated nosocomial pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile, Vancomycin-resistant enterococci (VRE), Klebsiella, Acinetobacter and other problematic Gram negatives. HPV decontamination can be applied safely as part of an infection control programme even where expensive electronic equipment is situated. HPV decontamination has proven material compatibility so all equipment can be safely decontaminated in situ with no detrimental effect on performance or aesthetics. This is critical during the "deep clean" process where these areas have traditionally been hard to reach or where the decontaminants are incompatible with sensitive electronics, particularly chlorine-based products (including bleach). Bioquell products and services have been developed for the bio-decontamination of hospital facilities and equipment, from wards and ICU's, to Category III laboratories. HPV is also effective against Mycobacterium tuberculosis. The efficacy of the process is validated using Tyvek® pouched 6-log Geobacillus stearothermophilus (spore) biological indicators. Bioquell can provide Q-10 equipment purchase (including training) or a number of decontamination service options as part of an infection control programme. When considering which decontamination method to choose, there are several factors which need consideration:
|
Quick Links
NHS News Update
Bioquell Q-10 procurement now available through Buying Solutions for NHS hospitals and trusts: 
Request a Brochure 
PASA Approval 
Showcase Hospital Program Report 
Rapid Review Panel Level 1 
Selected Quotes 
Awards 
Selected Research 
|
